Global Lyme Disease Testing Market Size & Outlook

The lyme disease testing industry worldwide is expected to reach a projected revenue of US$ 18,566.7 thousand by 2030. A compound annual growth rate of 8% is expected of the worldwide lyme disease testing industry from 2024 to 2030.
Revenue, 2023 (US$K)
$10,853.0
Forecast, 2030 (US$K)
$18,566.7
CAGR, 2024 - 2030
8%
Report Coverage
Worldwide

Global lyme disease testing market highlights

  • The global lyme disease testing market generated a revenue of USD 10,853.0 thousand in 2023 and is expected to reach USD 18,566.7 thousand by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 8% by 2030.
  • In terms of segment, igra testing accounted for a revenue of USD 1,232.0 thousand in 2023.
  • IGRA Testing is the most lucrative technology segment registering the fastest growth during the forecast period.
  • In terms of region, Europe was the largest revenue generating market in 2023.
  • Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 10,853.0 thousand
Market revenue in 2030USD 18,566.7 thousand
Growth rate8% (CAGR from 2023 to 2030)
Largest segmentIgra testing
Fastest growing segmentIGRA Testing
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD thousand
Market segmentationIGRA Testing

Other key industry trends

  • In terms of revenue, the North America accounted for 40.7% of the global lyme disease testing market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Kuwait is the fastest growing regional market and is projected to reach USD 3.2 thousand by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Lyme Disease Testing Market Companies

Name Profile # Employees HQ Website

Global lyme disease testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lyme disease testing market will help companies and investors design strategic landscapes.


Igra testing was the largest segment with a revenue share of 11.35% in 2023. Horizon Databook has segmented the Global lyme disease testing market based on igra testing covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Lyme Disease Testing Technology Outlook (Revenue, USD Thousand, 2018-2030)
    • IGRA Testing
    • Others
  • Global Lyme Disease Testing Test Outlook (Revenue, USD Thousand, 2018-2030)
    • Serological Test
      • ELISA
      • Western Blot
    • Lymphocytic Transformation Test
    • Urine Antigen Testing
    • Immunofluorescent Staining
    • Nucleic Acid Test
  • Global Lyme Disease Testing Sample Outlook (Revenue, USD Thousand, 2018-2030)
    • Blood
    • Urine
    • CSF
    • Others
  • Global Lyme Disease Testing End Use Outlook (Revenue, USD Thousand, 2018-2030)
    • Hospitals
    • Diagnostic Laboratories
    • Others

Reasons to subscribe to Global lyme disease testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global lyme disease testing market databook

  • Our clientele includes a mix of lyme disease testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global lyme disease testing market , including forecasts for subscribers. This global databook contains high-level insights into Global lyme disease testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global lyme disease testing market size, by regions, 2018-2030 (US$K)

Top 10 countries: Lyme disease testing market size, 2023 (US$K)

Global lyme disease testing market share, by technology, 2023 & 2030 (%, US$K)

Lyme disease testing market: Opportunity assessment by country

Global lyme disease testing market, by region, 2023 (US$K)

Global lyme disease testing market size, by regions, 2018-2030 (US$K)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more